Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04263467 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)

Study acronym: HIAIM
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 70 to confirmed 54
    • Primary completion date changed from estimate of Oct 1, 2025 to Jan 22, 2024
    • Site details revised
    v6
  2. Primary completion date: Oct 1, 2023 to Oct 1, 2025
    • Study completion date: Dec 31, 2023 to Dec 31, 2025
    v5
  3. Primary completion date: Feb 15, 2023 to Oct 1, 2023
    • Study completion date: May 15, 2023 to Dec 31, 2023
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  5. Primary completion date: Jun 1, 2022 to Feb 15, 2023
    • Start date: Mar 1, 2020 to Aug 17, 2020
    • Study completion date: Oct 31, 2022 to May 15, 2023
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Herlev Hospital
27 trials monitored
See 3 trials at risk
Lung Cancer
4,790 trials monitored
See 263 trials at risk
The purpose of this study is to investigate if high-intensive training can mobilize and activate the immune system, and thereby enhance the effect of the conventional treatment of lung cancer patients. An important aspect of this study will investigate if the presence of various proteins and cells in blood and tumor biopsies can verify or predict the effect of the high-intensive training. In this clinical trial, patients with lung cancer will combine their conventional therapy with a six-week exercise program.
Trial Details
NCT Number NCT04263467
Lead Sponsor Herlev Hospital
Conditions
(from sponsor)		 Cancer, Cancer of Lung
Related terms Lung Neoplasms, Neoplasms
Enrollment 54 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov